chr3-52075825-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_015426.5(POC1A):c.*62A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.203 in 1,189,084 control chromosomes in the GnomAD database, including 31,017 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.26 ( 6225 hom., cov: 32)
Exomes 𝑓: 0.19 ( 24792 hom. )
Consequence
POC1A
NM_015426.5 3_prime_UTR
NM_015426.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.45
Genes affected
POC1A (HGNC:24488): (POC1 centriolar protein A) POC1 proteins contain an N-terminal WD40 domain and a C-terminal coiled coil domain and are part of centrosomes. They play an important role in basal body and cilia formation. This gene encodes one of the two POC1 proteins found in humans. Mutations in this gene result in short stature, onychodysplasia, facial dysmorphism, and hypotrichosis (SOFT) syndrome. [provided by RefSeq, Sep 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 3-52075825-T-C is Benign according to our data. Variant chr3-52075825-T-C is described in ClinVar as [Benign]. Clinvar id is 1265846.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.432 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POC1A | NM_015426.5 | c.*62A>G | 3_prime_UTR_variant | 11/11 | ENST00000296484.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POC1A | ENST00000296484.7 | c.*62A>G | 3_prime_UTR_variant | 11/11 | 1 | NM_015426.5 | P1 | ||
POC1A | ENST00000394970.6 | c.*62A>G | 3_prime_UTR_variant | 10/10 | 1 | ||||
POC1A | ENST00000474012.1 | c.*62A>G | 3_prime_UTR_variant | 11/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.257 AC: 39080AN: 151970Hom.: 6195 Cov.: 32
GnomAD3 genomes
AF:
AC:
39080
AN:
151970
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.195 AC: 201877AN: 1036996Hom.: 24792 Cov.: 13 AF XY: 0.192 AC XY: 101835AN XY: 531752
GnomAD4 exome
AF:
AC:
201877
AN:
1036996
Hom.:
Cov.:
13
AF XY:
AC XY:
101835
AN XY:
531752
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.258 AC: 39171AN: 152088Hom.: 6225 Cov.: 32 AF XY: 0.262 AC XY: 19446AN XY: 74340
GnomAD4 genome
AF:
AC:
39171
AN:
152088
Hom.:
Cov.:
32
AF XY:
AC XY:
19446
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1311
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at